Identifying cardiac safety signals of disproportionate reporting for CGRP antagonists: evidence from the FDA Adverse Event Reporting System

Naunyn-Schmiedeberg s Archives of Pharmacology 2026

View at publisher

Authors: Shuaimin Xu, Weijuan Song, Yanhong Wang, Yang Zhao

DOI: 10.1007/s00210-026-05116-z

Cited by: 1

References: 50

Fields of Study & Subjects

Migraine and Headache Studies Pharmacovigilance and Adverse Drug Reactions Respiratory and Cough-Related Research

References 50